Nrf2 Is a Potential Modulator for Orchestrating Iron Homeostasis and Redox Balance in Cancer Cells
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nrf2 Is a Potential Modulator for Orchestrating Iron Homeostasis and Redox Balance in Cancer Cells
Authors
Keywords
-
Journal
Frontiers in Cell and Developmental Biology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-09-13
DOI
10.3389/fcell.2021.728172
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Broadening horizons: the role of ferroptosis in cancer
- (2021) Xin Chen et al. Nature Reviews Clinical Oncology
- Iron Metabolism in the Tumor Microenvironment—Implications for Anti-Cancer Immune Response
- (2021) Alessandro Sacco et al. Cells
- The Multifaceted Regulation of Mitochondria in Ferroptosis
- (2021) Hao Wu et al. Life-Basel
- Therapeutic potential of iron chelators on osteoporosis and their cellular mechanisms
- (2021) Jian Zhang et al. BIOMEDICINE & PHARMACOTHERAPY
- Ferroptosis, radiotherapy, and combination therapeutic strategies
- (2021) Guang Lei et al. Protein & Cell
- Antibodies Targeting the Transferrin Receptor 1 (TfR1) as Direct Anti-cancer Agents
- (2021) Pierre V. Candelaria et al. Frontiers in Immunology
- Lipoxin A4 protects primary spinal cord neurons from Erastin‐induced ferroptosis by activating the Akt / Nrf2 / HO‐1 signaling pathway
- (2021) Na Wei et al. FEBS Open Bio
- Iron metabolism and iron disorders revisited in the hepcidin era
- (2020) Clara Camaschella et al. HAEMATOLOGICA
- FBXL5 Regulates IRP2 Stability in Iron Homeostasis via an Oxygen-Responsive [2Fe2S] Cluster
- (2020) Hui Wang et al. MOLECULAR CELL
- Nrf2 and Ferroptosis: A New Research Direction for Neurodegenerative Diseases
- (2020) Xiaohua Song et al. Frontiers in Neuroscience
- Oxidative Stress in Cancer
- (2020) John D. Hayes et al. CANCER CELL
- Nrf2 knockout dysregulates iron metabolism and increases the hemolysis through ROS in aging mice
- (2020) Zhenzhen Liu et al. LIFE SCIENCES
- Iron and cancer: 2020 Vision
- (2020) Suzy V. Torti et al. CANCER RESEARCH
- NRF2 activation promotes aggressive lung cancer and associates with poor clinical outcomes
- (2020) Anju Singh et al. CLINICAL CANCER RESEARCH
- Ferroptosis in Cancer Treatment: Another Way to Rome
- (2020) Yinan Wu et al. Frontiers in Oncology
- Iron Metabolism in Ferroptosis
- (2020) Xin Chen et al. Frontiers in Cell and Developmental Biology
- Melatonin Suppresses Ferroptosis Induced by High Glucose via Activation of the Nrf2/HO-1 Signaling Pathway in Type 2 Diabetic Osteoporosis
- (2020) Hongdong Ma et al. Oxidative Medicine and Cellular Longevity
- NRF2 in Cardiovascular Diseases: a Ray of Hope!
- (2020) Ruju Vashi et al. Journal of Cardiovascular Translational Research
- A recycling anti-transferrin receptor-1 monoclonal antibody as an efficient therapy for erythroleukemia through target up-regulation and antibody-dependent cytotoxic effector functions
- (2019) Madeline Neiveyans et al. mAbs
- Iron levels, genes involved in iron metabolism and antioxidative processes and lung cancer incidence
- (2019) Grzegorz Mariusz Sukiennicki et al. PLoS One
- Iron accentuated reactive oxygen species release by NADPH oxidase in activated microglia contributes to oxidative stress in vitro
- (2019) Young J. Yauger et al. Journal of Neuroinflammation
- Disruption of FBXL5-mediated cellular iron homeostasis promotes liver carcinogenesis
- (2019) Yoshiharu Muto et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Different forms and sources of iron in relation to colorectal cancer risk: a case–control study in China
- (2019) Hong Luo et al. BRITISH JOURNAL OF NUTRITION
- Targeting Ferroptosis to Iron Out Cancer
- (2019) Behrouz Hassannia et al. CANCER CELL
- Potential Applications of NRF2 Inhibitors in Cancer Therapy
- (2019) Emiliano Panieri et al. Oxidative Medicine and Cellular Longevity
- Nrf2 in cancers: A double‐edged sword
- (2019) Shijia Wu et al. Cancer Medicine
- Iron intake, body iron status, and risk of breast cancer: a systematic review and meta-analysis
- (2019) Vicky C. Chang et al. BMC CANCER
- Nrf2 Activation Promotes Lung Cancer Metastasis by Inhibiting the Degradation of Bach1
- (2019) Luca Lignitto et al. CELL
- Mitochondria-specific drug release and reactive oxygen species burst induced by polyprodrug nanoreactors can enhance chemotherapy
- (2019) Wenjia Zhang et al. Nature Communications
- Iron homeostasis and iron-regulated ROS in cell death, senescence and human diseases
- (2019) Toshitaka Nakamura et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Dual roles and therapeutic potential of Keap1-Nrf2 pathway in pancreatic cancer: a systematic review
- (2019) Jiang-Jiang Qin et al. Cell Communication and Signaling
- Role of KEAP1/NFE2L2 mutations in the chemotherapeutic response of non-small cell lung cancer patients
- (2019) Youngtae Jeong et al. CLINICAL CANCER RESEARCH
- Iron and lung cancer
- (2019) Yanbin Kuang et al. CANCER LETTERS
- YTHDF1 links hypoxia adaptation and non-small cell lung cancer progression
- (2019) Yulin Shi et al. Nature Communications
- The expression of p‐p62 and nuclear Nrf2 in esophageal squamous cell carcinoma and association with radioresistance
- (2019) Zhe Wang et al. Thoracic Cancer
- The Role of Nrf2 Activity in Cancer Development and Progression
- (2019) Alina-Andreea Zimta et al. Cancers
- Gastrodin protects against glutamate-induced ferroptosis in HT-22 cells through Nrf2/HO-1 signaling pathway
- (2019) Ting Jiang et al. TOXICOLOGY IN VITRO
- Nrf2-Keap1 signaling in oxidative and reductive stress
- (2018) Ilaria Bellezza et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Dysregulation of NRF2 in Cancer: from Molecular Mechanisms to Therapeutic Opportunities
- (2018) Byung-Jin Jung et al. Biomolecules & Therapeutics
- Significance of serum ferritin as a prognostic factor in advanced hepatobiliary cancer patients treated with Korean medicine: a retrospective cohort study
- (2018) Anna Song et al. BMC Complementary and Alternative Medicine
- Heme oxygenase-1 mediates BAY 11–7085 induced ferroptosis
- (2018) Ling-Chu Chang et al. CANCER LETTERS
- Mitochondrial rescue prevents glutathione peroxidase-dependent ferroptosis
- (2018) Anja Jelinek et al. FREE RADICAL BIOLOGY AND MEDICINE
- Suppression of NRF2/ARE by convallatoxin sensitizes A549 cells to 5-FU-mediated apoptosis
- (2018) June Lee et al. FREE RADICAL RESEARCH
- Metformin Induces Apoptosis and Alters Cellular Responses to Oxidative Stress in Ht29 Colon Cancer Cells: Preliminary Findings
- (2018) Paola Sena et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Repurposing of the CDK inhibitor PHA-767491 as a NRF2 inhibitor drug candidate for cancer therapy via redox modulation
- (2018) Hsiu-Yu Liu et al. INVESTIGATIONAL NEW DRUGS
- Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma
- (2018) Behrouz Hassannia et al. JOURNAL OF CLINICAL INVESTIGATION
- Isoniazid induces apoptosis: Role of oxidative stress and inhibition of nuclear translocation of nuclear factor (erythroid-derived 2)-like 2 (Nrf2)
- (2018) Ajeet Kumar Verma et al. LIFE SCIENCES
- UVA Irradiation Enhances Brusatol-Mediated Inhibition of Melanoma Growth by Downregulation of the Nrf2-Mediated Antioxidant Response
- (2018) Mei Wang et al. Oxidative Medicine and Cellular Longevity
- Oridonin exerts anticancer effect on osteosarcoma by activating PPAR-γ and inhibiting Nrf2 pathway
- (2018) Ying Lu et al. Cell Death & Disease
- Chrysin suppresses proliferation, migration, and invasion in glioblastoma cell lines via mediating the ERK/Nrf2 signaling pathway
- (2018) Juan Wang et al. Drug Design Development and Therapy
- Unsolved mysteries: How does lipid peroxidation cause ferroptosis?
- (2018) Huizhong Feng et al. PLOS BIOLOGY
- Iron and Cancer
- (2018) Suzy V. Torti et al. Annual Review of Nutrition
- Ferritinophagy/ferroptosis: Iron-related newcomers in human diseases
- (2018) Mingzhu Tang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Mitochondrial Iron in Human Health and Disease
- (2018) Diane M. Ward et al. Annual Review of Physiology
- Haem iron intake and risk of lung cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort
- (2018) Heather A. Ward et al. EUROPEAN JOURNAL OF CLINICAL NUTRITION
- Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer
- (2018) Daiha Shin et al. FREE RADICAL BIOLOGY AND MEDICINE
- Role of Mitochondria in Ferroptosis
- (2018) Minghui Gao et al. MOLECULAR CELL
- Metformin Sensitizes Non-small Cell Lung Cancer Cells to an Epigallocatechin-3-Gallate (EGCG) Treatment by Suppressing the Nrf2/HO-1 Signaling Pathway
- (2017) Chenxiao Yu et al. International Journal of Biological Sciences
- Ferritin, cellular iron storage and regulation
- (2017) Paolo Arosio et al. IUBMB LIFE
- NFS1 undergoes positive selection in lung tumours and protects cells from ferroptosis
- (2017) Samantha W. Alvarez et al. NATURE
- A clinical drug library screen identifies clobetasol propionate as an NRF2 inhibitor with potential therapeutic efficacy in KEAP1 mutant lung cancer
- (2017) E-J Choi et al. ONCOGENE
- Iron addiction: a novel therapeutic target in ovarian cancer
- (2017) D Basuli et al. ONCOGENE
- Wogonin reversed resistant human myelogenous leukemia cells via inhibiting Nrf2 signaling by Stat3/NF-κB inactivation
- (2017) Xuefen Xu et al. Scientific Reports
- BID links ferroptosis to mitochondrial cell death pathways
- (2017) Sandra Neitemeier et al. Redox Biology
- Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis
- (2017) Jong-Lyel Roh et al. Redox Biology
- Role of NF-E2 related factor 2 (Nrf2) on chemotherapy resistance in acute myeloid leukemia (AML) and the effect of pharmacological inhibition of Nrf2
- (2017) Sreeja Karathedath et al. PLoS One
- Effects of Ferroportin-Mediated Iron Depletion in Cells Representative of Different Histological Subtypes of Prostate Cancer
- (2017) Zhiyong Deng et al. ANTIOXIDANTS & REDOX SIGNALING
- Higher concentrations of serum iron and transferrin saturation but not serum ferritin are associated with cancer outcomes
- (2016) Anita CG Chua et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Targeting Nrf2 with wogonin overcomes cisplatin resistance in head and neck cancer
- (2016) Eun Hye Kim et al. APOPTOSIS
- Autophagy promotes ferroptosis by degradation of ferritin
- (2016) Wen Hou et al. Autophagy
- CISD1 inhibits ferroptosis by protection against mitochondrial lipid peroxidation
- (2016) Hua Yuan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Downregulation of Nrf2 by the combination of TRAIL and Valproic acid induces apoptotic cell death of TRAIL-resistant papillary thyroid cancer cells via suppression of Bcl-xL
- (2016) Hyun-Young Cha et al. CANCER LETTERS
- Iron Uptake via DMT1 Integrates Cell Cycle with JAK-STAT3 Signaling to Promote Colorectal Tumorigenesis
- (2016) Xiang Xue et al. Cell Metabolism
- Ferroptosis is an autophagic cell death process
- (2016) Minghui Gao et al. CELL RESEARCH
- Serum ferritin level is a prognostic marker in patients with peripheral T-cell lymphoma
- (2016) S. Koyama et al. International Journal of Laboratory Hematology
- Iron Deprivation Induces Transcriptional Regulation of Mitochondrial Biogenesis
- (2016) Jarred W. Rensvold et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mitochondria and Cancer
- (2016) Wei-Xing Zong et al. MOLECULAR CELL
- Recurrent Loss of NFE2L2 Exon 2 Is a Mechanism for Nrf2 Pathway Activation in Human Cancers
- (2016) Leonard D. Goldstein et al. Cell Reports
- Serum Ferritin as a Prognostic Biomarker for Survival in Relapsed or Refractory Metastatic Colorectal Cancer
- (2016) Sookyung Lee et al. Journal of Cancer
- Selective antagonization of activated Nrf2 and inhibition of cancer cell proliferation by procyanidins from Cinnamomi Cortex extract
- (2015) Tomokazu Ohnuma et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Hereditary hemochromatosis type 1 phenotype modifiers in Italian patients. The controversial role of variants in HAMP, BMP2, FTL and SLC40A1 genes
- (2015) Francesca Clementina Radio et al. BLOOD CELLS MOLECULES AND DISEASES
- Preferential Iron Trafficking Characterizes Glioblastoma Stem-like Cells
- (2015) David L. Schonberg et al. CANCER CELL
- Hepcidin Regulation in Prostate and Its Disruption in Prostate Cancer
- (2015) Lia Tesfay et al. CANCER RESEARCH
- Brusatol provokes a rapid and transient inhibition of Nrf2 signaling and sensitizes mammalian cells to chemical toxicity—implications for therapeutic targeting of Nrf2
- (2015) Adedamola Olayanju et al. FREE RADICAL BIOLOGY AND MEDICINE
- The ins and outs of erythroid heme transport
- (2015) C. Cao et al. HAEMATOLOGICA
- Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells
- (2015) Xiaofang Sun et al. HEPATOLOGY
- Glutaminolysis and Transferrin Regulate Ferroptosis
- (2015) Minghui Gao et al. MOLECULAR CELL
- NRF2 regulates serine biosynthesis in non–small cell lung cancer
- (2015) Gina M DeNicola et al. NATURE GENETICS
- Heme oxygenase-1 accelerates erastin-induced ferroptotic cell death
- (2015) Min-Young Kwon et al. Oncotarget
- The ins and outs of erythroid heme transport
- (2015) C. Cao et al. HAEMATOLOGICA
- Luteolin inhibits the Nrf2 signaling pathway and tumor growth in vivo
- (2014) Song Chian et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Wogonin reverses multi-drug resistance of human myelogenous leukemia K562/A02 cells via downregulation of MRP1 expression by inhibiting Nrf2/ARE signaling pathway
- (2014) Xuefen Xu et al. BIOCHEMICAL PHARMACOLOGY
- Retinoic acid synergizes ATO-mediated cytotoxicity by precluding Nrf2 activity in AML cells
- (2014) M Valenzuela et al. BRITISH JOURNAL OF CANCER
- High Serum Iron Is Associated with Increased Cancer Risk
- (2014) C. P. Wen et al. CANCER RESEARCH
- Oncogenic KRAS Confers Chemoresistance by Upregulating NRF2
- (2014) S. Tao et al. CANCER RESEARCH
- NADPH oxidases: an overview from structure to innate immunity-associated pathologies
- (2014) Arvind Panday et al. Cellular & Molecular Immunology
- Metformin induces microRNA-34a to downregulate the Sirt1/Pgc-1α/Nrf2 pathway, leading to increased susceptibility of wild-type p53 cancer cells to oxidative stress and therapeutic agents
- (2014) Minh Truong Do et al. FREE RADICAL BIOLOGY AND MEDICINE
- Wogonin-enhanced reactive oxygen species-induced apoptosis and potentiated cytotoxic effects of chemotherapeutic agents by suppression Nrf2-mediated signaling in HepG2 cells
- (2014) C. Qian et al. FREE RADICAL RESEARCH
- Serum ferritin as a new prognostic factor in hepatocellular carcinoma patients treated with radiofrequency ablation
- (2014) Antonio Facciorusso et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy
- (2014) Joseph D. Mancias et al. NATURE
- Clinical significance of serum ferritin in elderly patients with primary lung carcinoma
- (2014) Mei Ji et al. TUMOR BIOLOGY
- The significance of ferritin in cancer: Anti-oxidation, inflammation and tumorigenesis
- (2013) Ahmed A. Alkhateeb et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Iron metabolism and risk of cancer in the Swedish AMORIS study
- (2013) Anjali Gaur et al. CANCER CAUSES & CONTROL
- CUL3 and NRF2 Mutations Confer an NRF2 Activation Phenotype in a Sporadic Form of Papillary Renal Cell Carcinoma
- (2013) A. Ooi et al. CANCER RESEARCH
- Epidemiological and nonclinical studies investigating effects of iron in carcinogenesis—A critical review
- (2013) Yves Beguin et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- The Noncytotoxic Dose of Sorafenib Sensitizes Bel-7402/5-FU Cells to 5-FU by Down-Regulating 5-FU-Induced Nrf2 Expression
- (2013) Suna Zhou et al. DIGESTIVE DISEASES AND SCIENCES
- Metformin inhibits heme oxygenase-1 expression in cancer cells through inactivation of Raf-ERK-Nrf2 signaling and AMPK-independent pathways
- (2013) Minh Truong Do et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Long-term dietary heme iron and red meat intake in relation to endometrial cancer risk
- (2012) Jeanine M Genkinger et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
- (2012) Scott J. Dixon et al. CELL
- Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptible to apoptosis through decreased proteasomal gene expression and proteasome activity
- (2012) A Arlt et al. ONCOGENE
- Ferritin as an independent mortality predictor in patients with pancreas cancer. Results of a pilot study
- (2012) Marta Kalousová et al. TUMOR BIOLOGY
- Nrf2 regulates ferroportin 1-mediated iron efflux and counteracts lipopolysaccharide-induced ferroportin 1 mRNA suppression in macrophages
- (2011) Nobuhiko Harada et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- The transferrin receptor and the targeted delivery of therapeutic agents against cancer
- (2011) Tracy R. Daniels et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Renal Cyst Formation in Fh1-Deficient Mice Is Independent of the Hif/Phd Pathway: Roles for Fumarate in KEAP1 Succination and Nrf2 Signaling
- (2011) Julie Adam et al. CANCER CELL
- Heavy Chain Ferritin siRNA Delivered by Cationic Liposomes Increases Sensitivity of Cancer Cells to Chemotherapeutic Agents
- (2011) X. Liu et al. CANCER RESEARCH
- H Ferritin Gene Silencing in a Human Metastatic Melanoma Cell Line: A Proteomic Analysis
- (2011) Maddalena Di Sanzo et al. JOURNAL OF PROTEOME RESEARCH
- Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
- (2011) Gina M. DeNicola et al. NATURE
- Beneficial Role of Nrf2 in Regulating NADPH Generation and Consumption
- (2011) Kai Connie Wu et al. TOXICOLOGICAL SCIENCES
- Role of ferritin alterations in human breast cancer cells
- (2010) Svitlana I. Shpyleva et al. BREAST CANCER RESEARCH AND TREATMENT
- Heme controls ferroportin1 (FPN1) transcription involving Bach1, Nrf2 and a MARE/ARE sequence motif at position -7007 of the FPN1 promoter
- (2010) S. Marro et al. HAEMATOLOGICA
- The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1
- (2010) Masaaki Komatsu et al. NATURE CELL BIOLOGY
- Ferroportin and Iron Regulation in Breast Cancer Progression and Prognosis
- (2010) Z. K. Pinnix et al. Science Translational Medicine
- Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen
- (2009) Hany Onsy Habashy et al. BREAST CANCER RESEARCH AND TREATMENT
- Direct Interaction between Nrf2 and p21Cip1/WAF1 Upregulates the Nrf2-Mediated Antioxidant Response
- (2009) Weimin Chen et al. MOLECULAR CELL
- Hypermethylation of the Keap1 gene in human lung cancer cell lines and lung cancer tissues
- (2008) Rui Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Synthetic Lethal Screening Identifies Compounds Activating Iron-Dependent, Nonapoptotic Cell Death in Oncogenic-RAS-Harboring Cancer Cells
- (2008) Wan Seok Yang et al. CHEMISTRY & BIOLOGY
- Decreased Cancer Risk After Iron Reduction in Patients With Peripheral Arterial Disease: Results From a Randomized Trial
- (2008) L. R. Zacharski et al. JNCI-Journal of the National Cancer Institute
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started